NEWS & MEDIA

UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016

November 2, 2016

GAITHERSBURG, Md.Nov. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will host an Investor and Analyst update as part of its third quarter financial results conference call and webcast after the close of U.S. financial markets on Wednesday, November 9, 2016.

Management will host a conference call to discuss the quarterly financial results and provide an update on corporate activities. Please be sure to join the webcast in order to access the slide presentation.

Conference call details are as follows:

Date:

Wednesday, November 9, 2016

Time:

4:30 p.m. U.S. Eastern Time (ET)

Dial-in number:

(877) 212-6076 (Domestic) or (707) 287-9331 (International)

Passcode: 

10126707

Webcast:  

www.novavax.com, “Investors”/ “Events”

 

 

 

Conference call replay:

Dates:

Starting at 8:30 p.m. ET, November 9, 2016 until November 16, 2016

Dial-in number:

(855) 859-2056 (Domestic) or (404) 537-3406 (International)

Passcode:

10126707

Webcast:  

www.novavax.com, “Investors”/ “Events”

 

 

 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:

Novavax, Inc.Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

[email protected]
240-268-2000